Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.87%9.14B | -3.23%8.55B | 20.80%2.14B | -12.12%2.15B | -15.83%1.97B | 0.59%2.29B | -0.03%8.83B | -19.08%1.77B | 3.65%2.44B | 9.49%2.34B |
| Cost of revenue | 7.40%7.01B | 0.09%6.53B | 17.36%1.67B | -4.67%1.66B | -13.23%1.46B | 3.79%1.74B | 4.57%6.53B | -10.61%1.42B | 7.83%1.75B | 13.76%1.68B |
| Gross profit | 5.16%2.12B | -12.61%2.02B | 34.79%470.93M | -30.76%482.82M | -22.45%511.42M | -8.32%552.56M | -11.10%2.31B | -41.56%349.37M | -5.51%697.3M | -0.08%659.45M |
| Operating expense | 11.06%1.79B | 0.22%1.61B | 5.08%401.24M | 2.90%430.26M | -5.44%399.26M | -1.29%380.76M | 8.53%1.61B | -6.29%381.82M | 16.76%418.14M | 13.16%422.24M |
| Selling and administrative expenses | 11.06%1.79B | 0.22%1.61B | 5.08%401.24M | 2.90%430.26M | -5.44%399.26M | -1.29%380.76M | 8.53%1.61B | -6.29%381.82M | 16.76%418.14M | 13.16%422.24M |
| -Selling and marketing expense | 12.64%433.13M | -1.99%384.51M | ---- | ---- | ---- | ---- | 10.20%392.32M | ---- | ---- | ---- |
| -General and administrative expense | 10.56%1.36B | 0.94%1.23B | 259.26%16.72M | 2.90%430.26M | -5.44%399.26M | -1.29%380.76M | 8.00%1.22B | -120.41%-10.5M | 16.76%418.14M | 13.16%422.24M |
| Operating profit | -18.21%332.24M | -42.04%406.22M | 314.79%69.69M | -81.17%52.57M | -52.72%112.16M | -20.83%171.8M | -37.17%700.91M | -117.04%-32.45M | -26.50%279.16M | -17.30%237.21M |
| Net non-operating interest income (expenses) | -43.28%3.24M | 10.12%5.71M | 0.15%1.34M | 5.22%1.51M | 17.28%1.49M | 19.95%1.38M | -50.82%5.19M | -54.73%1.33M | -46.76%1.44M | -48.66%1.27M |
| Non-operating interest income | 82.09%10.88M | 9.53%5.97M | -3.61%1.39M | 6.29%1.59M | 18.04%1.56M | 19.98%1.44M | -49.69%5.45M | -52.62%1.44M | -46.07%1.5M | -47.84%1.32M |
| Non-operating interest expense | 2,815.27%7.64M | -1.87%262K | -51.43%51K | 33.33%76K | 36.54%71K | 20.75%64K | -8.87%267K | 16.67%105K | -19.72%57K | -14.75%52K |
| Net investment income | -122.42%-5.82M | -12.20%25.94M | -16.80%18.88M | 60.31%-12.59M | -52.22%4.01M | -48.18%15.64M | 62.96%29.55M | 102.18%22.69M | -748.76%-31.73M | 281.52%8.4M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 93.63%-4.76M | -1,235.59%-74.65M | -177.47%-47.75M | 14.85%-23.64M | -106.28%-2.54M | 32.30%-723K | 82.60%-5.59M | -243.86%-17.21M | -15.82%-27.76M | 1,454.00%40.44M |
| Less:Other special charges | -93.63%4.76M | 1,235.59%74.65M | 177.47%47.75M | -14.85%23.64M | 106.28%2.54M | -32.30%723K | -82.60%5.59M | 243.86%17.21M | 15.82%27.76M | -1,454.00%-40.44M |
| Other non-operating income (expenses) | 16.28%46.85M | 2,286.97%40.29M | 328.03%2.65M | 345.70%40.72M | 71.45%-1.13M | 16.18%-1.95M | 118.74%1.69M | 58.01%-1.16M | 515.84%9.14M | -31.64%-3.96M |
| Income before tax | -7.87%371.76M | -44.86%403.52M | 267.23%44.81M | -74.56%58.57M | -59.77%113.99M | -24.00%186.15M | -33.67%731.74M | -113.62%-26.8M | -36.26%230.24M | -0.75%283.36M |
| Income tax | -56.63%53.33M | -34.43%122.97M | 110.51%5.84M | -69.82%21.44M | -61.44%35.63M | -24.60%60.07M | -34.27%187.55M | -869.59%-55.55M | -37.46%71.03M | 9.44%92.39M |
| Net income | 13.50%318.42M | -48.45%280.55M | 35.56%38.98M | -76.68%37.13M | -58.97%78.36M | -23.71%126.08M | -33.46%544.19M | -84.84%28.75M | -35.71%159.21M | -5.03%190.97M |
| Net income continuous operations | 13.50%318.42M | -48.45%280.55M | 35.56%38.98M | -76.68%37.13M | -58.97%78.36M | -23.71%126.08M | -33.46%544.2M | -84.83%28.75M | -35.71%159.21M | -5.03%190.97M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 13.50%318.42M | -48.45%280.55M | 35.56%38.98M | -76.68%37.13M | -58.97%78.36M | -23.71%126.08M | -33.46%544.19M | -84.84%28.75M | -35.71%159.21M | -5.03%190.97M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 13.50%318.42M | -48.45%280.55M | 35.56%38.98M | -76.68%37.13M | -58.97%78.36M | -23.71%126.08M | -33.46%544.19M | -84.84%28.75M | -35.71%159.21M | -5.03%190.97M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 13.34%109.76 | -48.45%96.84 | 35.58%13.45 | -76.67%12.82 | -58.97%27.05 | -23.70%43.52 | -33.46%187.84 | -84.84%9.92 | -35.71%54.96 | -5.01%65.92 |
| Diluted earnings per share | 13.34%109.76 | -48.45%96.84 | 35.58%13.45 | -76.68%12.8179 | -58.97%27.0483 | -23.70%43.52 | -33.46%187.84 | -84.84%9.92 | -35.71%54.9538 | -5.02%65.9156 |
| Dividend per share | 11.11%100 | 12.50%90 | 12.50%90 | 0 | 0 | 0 | 0.00%80 | 0.00%80 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |